All treatments have potential risks. MECTA does not provide medical advice. MECTA only sells its products to licensed health providers and hospitals, and does not have direct interaction with Electroconvulsive Therapy (ECT) patients. Because MECTA does not have direct interaction with patients, this website and the Patients and Families Booklet are two of the only ways to provide patients with warnings about ECT.

The following warnings were stipulated by the FDA to include in a Patients and Families booklet:

Warning: When used as intended this device provides short-term relief of symptoms. The long-term safety and effectiveness of ECT treatment has not been demonstrated.

Warning: ECT device use may be associated with disorientation, confusion, and memory problems.

Warning: Patients treated with ECT may experience manic symptoms (including euphoria and/or irritability, impulsivity, racing thoughts, distractibility, grandiosity, increased activity, talkativeness, and decreased need for sleep) or a worsening of the psychiatric symptoms they are being treated for.

If you would like to read the entire Patients and Families booklet, it can be downloaded here: Patients and Families Booklet